Using risk advancement periods to derive starting ages of colorectal cancer screening according to sex and polygenic risk score: Results from the UK Biobank
View ORCID ProfileXuechen Chen, Thomas Heisser, Rafael Cardoso, Michael Hoffmeister, View ORCID ProfileHermann Brenner
doi: https://doi.org/10.1101/2023.03.05.23286808
Xuechen Chen
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
2Medical Faculty Heidelberg, Heidelberg University, Heidelberg 69120, Germany
Thomas Heisser
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
2Medical Faculty Heidelberg, Heidelberg University, Heidelberg 69120, Germany
Rafael Cardoso
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
2Medical Faculty Heidelberg, Heidelberg University, Heidelberg 69120, Germany
Michael Hoffmeister
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
Hermann Brenner
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
3Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg 69120, Germany
4German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
Posted March 06, 2023.
Using risk advancement periods to derive starting ages of colorectal cancer screening according to sex and polygenic risk score: Results from the UK Biobank
Xuechen Chen, Thomas Heisser, Rafael Cardoso, Michael Hoffmeister, Hermann Brenner
medRxiv 2023.03.05.23286808; doi: https://doi.org/10.1101/2023.03.05.23286808
Using risk advancement periods to derive starting ages of colorectal cancer screening according to sex and polygenic risk score: Results from the UK Biobank
Xuechen Chen, Thomas Heisser, Rafael Cardoso, Michael Hoffmeister, Hermann Brenner
medRxiv 2023.03.05.23286808; doi: https://doi.org/10.1101/2023.03.05.23286808
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2977)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12836)
- Forensic Medicine (12)
- Gastroenterology (835)
- Genetic and Genomic Medicine (4636)
- Geriatric Medicine (426)
- Health Economics (733)
- Health Informatics (2951)
- Health Policy (1075)
- Hematology (394)
- HIV/AIDS (936)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4429)
- Nursing (238)
- Nutrition (653)
- Oncology (2301)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (504)
- Public and Global Health (7024)
- Radiology and Imaging (1556)
- Respiratory Medicine (924)
- Rheumatology (447)
- Sports Medicine (386)
- Surgery (493)
- Toxicology (60)
- Transplantation (213)
- Urology (185)